These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 13208908)

  • 1. The mode of action of quaternary ammonium type neuromuscular blocking agents.
    FOLDES FF
    Br J Anaesth; 1954 Nov; 26(6):394-8. PubMed ID: 13208908
    [No Abstract]   [Full Text] [Related]  

  • 2. RELATION BETWEEN STRUCTURE AND ACTION OF QUATERNARY AMMONIUM NEUROMUSCULAR BLOCKING AGENTS.
    TAYLOR DB; NEDERGAARD OA
    Physiol Rev; 1965 Jul; 45():523-54. PubMed ID: 14337567
    [No Abstract]   [Full Text] [Related]  

  • 3. SOME EFFECTS OF ALTERING ONIUM SUBSTITUENTS ON THE INTERNITROGEN DISTANCE IN GANGLIONIC AND NEUROMUSCULAR BLOCKING AGENTS.
    ELWORTHY PH
    J Pharm Pharmacol; 1964 Jun; 16():375-80. PubMed ID: 14200397
    [No Abstract]   [Full Text] [Related]  

  • 4. Relation of benzoquinonium to other neuromuscular blocking agents.
    HOUGS W; JOHANSEN S
    Acta Pharmacol Toxicol (Copenh); 1957; 13(4):410-9. PubMed ID: 13444003
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuromuscular blocking agents. VI. Linear tetra-, penta-, and hexa-onium compounds.
    EDWARDS D; STENLAKE JB; LEWIS JJ; STOTHERS F
    J Med Pharm Chem; 1961 Mar; 3():369-99. PubMed ID: 13889275
    [No Abstract]   [Full Text] [Related]  

  • 6. Mode of action of neuromuscular blocking agents.
    PATON WD
    Br J Anaesth; 1956 Oct; 28(10):470-80. PubMed ID: 13364109
    [No Abstract]   [Full Text] [Related]  

  • 7. Some NSN-tris quaternary neuromuscular blocking agents.
    EDWARDS D; LEWIS JJ; STENLAKE JB; ZOHA MS
    J Pharm Pharmacol; 1957 Dec; 9(12):1004-16. PubMed ID: 13492190
    [No Abstract]   [Full Text] [Related]  

  • 8. [Quaternary ammonium compounds among our drugs].
    ANTAL J; VEGH A
    Gyogyszeresz; 1953 Dec; 8(12):202-5. PubMed ID: 24542981
    [No Abstract]   [Full Text] [Related]  

  • 9. [REMARKS CONCERNING THE INFLUENCE OF STRUCTURE ON THE CURARIZING ACTION OF MOLECULES CONTAINING QUATERNARY AMMONIUM GROUPS].
    KUPFER D; TSOUCARIS G
    Therapie; 1964; 19():653-6. PubMed ID: 14182949
    [No Abstract]   [Full Text] [Related]  

  • 10. [Toxicity and curarizing property of polymethylene bisethyltheophylline quaternary ammonium salt].
    MORIN H
    C R Seances Soc Biol Fil; 1956 May; 150(1):164-6. PubMed ID: 13330318
    [No Abstract]   [Full Text] [Related]  

  • 11. The initial transient stimulating action of neuromuscular blocking agents in the cat.
    PAYNE JP
    Br J Anaesth; 1961 Jun; 33():285-8. PubMed ID: 13733672
    [No Abstract]   [Full Text] [Related]  

  • 12. Study on the central action of neuromuscular blocking agents.
    SAKUMA A
    Jpn J Pharmacol; 1959 Sep; 9():30-40. PubMed ID: 14440879
    [No Abstract]   [Full Text] [Related]  

  • 13. Action on central nervous system of compounds RP 3565 and RP 3697 and of tetramethylammonium and tetraethylammonium.
    SALAMA S; WRIGHT S
    Br J Pharmacol Chemother; 1952 Mar; 7(1):1-13. PubMed ID: 14904897
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuromuscular blocking agents.
    PATON WD; WAUD DR
    Br J Anaesth; 1962 Apr; 34():251-9. PubMed ID: 14484359
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuromuscular blocking agents.
    VAN MAANEN EF
    Am J Med; 1955 Nov; 19(5):669-72. PubMed ID: 13268461
    [No Abstract]   [Full Text] [Related]  

  • 16. The interaction of benzoquinonium and other neuromuscular blocking agents.
    HOUGS W; JOHANSEN SH
    Acta Pharmacol Toxicol (Copenh); 1958; 14(4):385-9. PubMed ID: 13594501
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of frequency of stimulation on the paralyzing dose of neuromuscular blocking agents.
    PRESTON JB; VAN MAANEN EF
    J Pharmacol Exp Ther; 1953 Feb; 107(2):165-71. PubMed ID: 13035653
    [No Abstract]   [Full Text] [Related]  

  • 18. [HL 8562 (Bistrimethylammoniumdecandibromide) as a muscle relaxant in the practice of narcosis].
    BARTH L; BOSSE W
    Dtsch Gesundheitsw; 1952 Aug; 7(33):1043-7. PubMed ID: 13020453
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ether oxides with quaternary ammonium functions].
    MORREN H; TROLIN S; STRUBBE H; GRIVSKY E
    J Pharm Belg; 1952; 7(7-8):295-307. PubMed ID: 12991199
    [No Abstract]   [Full Text] [Related]  

  • 20. Compatibility of neuromuscular blocking agents with barbiturates.
    BRITTON JB
    Anesthesiology; 1953 Jan; 14(1):92-3. PubMed ID: 13017021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.